ArticleThoracic cancer2019

Lactate dehydrogenase and baseline markers associated with clinical outcomes of advanced esophageal squamous cell carcinoma patients treated with camrelizumab (SHR-1210), a novel anti-PD-1 antibody.

Xi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.